Patent Pooling In Public Health

Burrone, Esteban

doi:10.2139/ssrn.3358839

Cited by 2 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This flexibility in licenses has helped in guiding the access to new patented treatment in low-and middle-income countries. 62 GlaxoSmithKline has also set up a patent pool for…”

Section: Medicines Patent Pool (Mpp) Model (2010)mentioning

confidence: 99%

Patent pools and innovation‐based approach in global healthcare crisis

Priyan

Gargate

2023

World Intellectual Property

View full text Add to dashboard Cite

During the COVID 2019 pandemic, the healthcare sector faced major jurisprudential questions about the intellectual property system. During this period, the world was in the midst of a healthcare crisis, wherein the debate between the reward for innovation versus accessibility to all at equitable rates have become intense. In a such challenging scenario, the scientific community were dedicated toward the research while the healthcare industry was indulging in arguments over the incentives on creation. In this paper, the authors, as IP researchers, argue that in a scenario where there is an intense dispute over innovation versus accessibility, probably patent pool can serve as a mechanism to handle the tussle. The authors have analyzed a few patent pool models that were chosen on the basis of the types of patents in the pool. Additionally, an attempt is made to scrutinize the laws governing patent pools in developed countries and developing countries. In doing so, the authors draw the benefits and limitations of the patent pools in healthcare. We follow a qualitative research methodology. The research is based on secondary data and has some limitations because of this.

show abstract

“…This flexibility in licenses has helped in guiding the access to new patented treatment in low-and middle-income countries. 62 GlaxoSmithKline has also set up a patent pool for…”

Section: Medicines Patent Pool (Mpp) Model (2010)mentioning

confidence: 99%

Patent pools and innovation‐based approach in global healthcare crisis

Priyan

Gargate

2023

World Intellectual Property

View full text Add to dashboard Cite

show abstract

“…These licenses may be granted directly to manufacturers, through bilateral licenses, or might be managed through NGOs or international organizations, such as the WHO, which organize a patent pool, a portfolio of patents held by various actors but that relate to the use of a same technology (OECD, 2011). While patent pools have existed for more than a hundred years in other fields of technology, they are a relatively new concept in public health (Burrone, 2018), with the Medicines Patent Pool established in 2010 being the first effective (and efficient) attempt (Juneja et al., 2017; Lampe & Moser, 2016; Martinelli et al., 2020; Galassso & Schankerman, 2020; Wang, 2020).…”

Section: A New Policy Framework and A Proposalmentioning

confidence: 99%

Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly

Florio

Gamba

2021

Ann Public Coop Econ

View full text Add to dashboard Cite

After a brief analysis of the causes underlying the failure of both governments and the pharma industry in terms of preparedness for the COVID‐19 pandemic, and after a discussion of further risks of health emergencies in the coming decades, this paper proposes a new public policy approach. The proposal aims at a major European initiative for the provision of research and development (R&D) in the biomedical field, based on public health priorities. A plan is discussed for an international, interconnected, transparent, science‐informed and publicly funded research infrastructure for pharmaceutical and biomedical research combined with a public enterprise: Biomed Europa. The proposed platform aims to identify research priorities in the public health sector, focusing its efforts on the development of preventive and therapeutic strategies against those diseases that will pose the greatest threats to human and social welfare over future decades. Biomed Europa could be managed as both an international research infrastructure, along the model of CERN, or the EMBL (European Molecular Biology Laboratory, Heidelberg) and as a knowledge‐intensive public enterprise with an industrial policy mission, such as the ESA (European Space Agency).

show abstract

Patent Pooling In Public Health

Cited by 2 publications

References 10 publications

Patent pools and innovation‐based approach in global healthcare crisis

Patent pools and innovation‐based approach in global healthcare crisis

Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly

Contact Info

Product

Resources

About